BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause severe respiratory failure leading to prolonged mechanical ventilation. Data are just emerging about the practice and outcomes of tracheostomy in these patients. We reviewed our experience with tracheostomies for SARS-CoV-2. METHODS: We retrospectively reviewed the demographics, comorbidities, timing of mechanical ventilation, tracheostomy, and intensive care unit and hospital lengths of stay in SARS-CoV-2 patients who received tracheostomies performed by the interventional pulmonary team. A tertiary care, teaching hospital in Chicago, Illinois. From March 2020 to April 2021, our center had 473 patients intubated for SARS-CoV-2, and 72 (15%) had percutaneous bedside tracheostomy performed by the interventional pulmonary team. RESULTS: Median time from intubation to tracheostomy was 20 (interquartile range: 16 to 25) days. Demographics and comorbidities were similar between early and late tracheostomy, but early tracheostomy was associated with shorter intensive care unit lengths of stay and a shorter total duration of ventilation. To date, 39 (54%) patients have been decannulated, 17 (24%) before hospital discharge; median time to decannulation was 22 (IQR: 18 to 36) days. Patients that were decannulated were younger (56 vs. 69 y). The rate of decannulation for survivors was 82%. No providers developed symptoms or tested positive for SARS-CoV-2. CONCLUSION: Tracheostomy enhances care for patients with prolonged respiratory failure from SARS-CoV-2 since early tracheostomy is associated with shorter duration of critical care, and decannulation rates are high for survivors. It furthermore appears safe for both patients and operators.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause severe respiratory failure leading to prolonged mechanical ventilation. Data are just emerging about the practice and outcomes of tracheostomy in these patients. We reviewed our experience with tracheostomies for SARS-CoV-2. METHODS: We retrospectively reviewed the demographics, comorbidities, timing of mechanical ventilation, tracheostomy, and intensive care unit and hospital lengths of stay in SARS-CoV-2 patients who received tracheostomies performed by the interventional pulmonary team. A tertiary care, teaching hospital in Chicago, Illinois. From March 2020 to April 2021, our center had 473 patients intubated for SARS-CoV-2, and 72 (15%) had percutaneous bedside tracheostomy performed by the interventional pulmonary team. RESULTS: Median time from intubation to tracheostomy was 20 (interquartile range: 16 to 25) days. Demographics and comorbidities were similar between early and late tracheostomy, but early tracheostomy was associated with shorter intensive care unit lengths of stay and a shorter total duration of ventilation. To date, 39 (54%) patients have been decannulated, 17 (24%) before hospital discharge; median time to decannulation was 22 (IQR: 18 to 36) days. Patients that were decannulated were younger (56 vs. 69 y). The rate of decannulation for survivors was 82%. No providers developed symptoms or tested positive for SARS-CoV-2. CONCLUSION: Tracheostomy enhances care for patients with prolonged respiratory failure from SARS-CoV-2 since early tracheostomy is associated with shorter duration of critical care, and decannulation rates are high for survivors. It furthermore appears safe for both patients and operators.
Authors: Wim Jonckheere; Michaël Mekeirele; Steven Hendrickx; Joop Jonckheer; Marc Diltoer; Idris Ghijselings; Matthias Raes; Domien Vanhonacker; Manu L G Malbrain; Ina Foulon; Frans Gordts; Daniel Jacobs-Tulleneers-Thevissen; Mark La Meir; Jan Nijs; Dirk Smets; Martijn Schoneveld; Ellen Van Eetvelde; Marian Vanhoeij; Katia Verbruggen; Guy Verfaillie; Paul Wischmeyer; Elisabeth De Waele Journal: Anaesthesiol Intensive Ther Date: 2020
Authors: Francesc Xavier Avilés-Jurado; Daniel Prieto-Alhambra; Nesly González-Sánchez; José de Ossó; Claudio Arancibia; María Jesús Rojas-Lechuga; Laura Ruiz-Sevilla; Joan Remacha; Irene Sánchez; Eduardo Lehrer-Coriat; Mauricio López-Chacón; Cristóbal Langdon; Josep María Guilemany; Francisco Larrosa; Isam Alobid; Manuel Bernal-Sprekelsen; Pedro Castro; Isabel Vilaseca Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-10-08 Impact factor: 6.223
Authors: Òscar Miró; Pere Llorens; Sònia Jiménez; Pascual Piñera; Guillermo Burillo-Putze; Alfonso Martín; Francisco Javier Martín-Sánchez; Eric Jorge García-Lamberetchs; Javier Jacob; Aitor Alquézar-Arbé; Josep Maria Mòdol; María Pilar López-Díez; Josep Maria Guardiola; Carlos Cardozo; Francisco Javier Lucas Imbernón; Alfons Aguirre Tejedo; Ángel García García; Martín Ruiz Grinspan; Ferran Llopis Roca; Juan González Del Castillo Journal: Chest Date: 2020-11-20 Impact factor: 9.410
Authors: Eric R Carlson; R Eric Heidel; Kyle Houston; Soheil Vahdani; Michael Winstead Journal: J Oral Maxillofac Surg Date: 2021-03-12 Impact factor: 1.895
Authors: Carla R Lamb; Neeraj R Desai; Luis Angel; Udit Chaddha; Ashutosh Sachdeva; Sonali Sethi; Hassan Bencheqroun; Hiren Mehta; Jason Akulian; A Christine Argento; Javier Diaz-Mendoza; Ali Musani; Septimiu Murgu Journal: Chest Date: 2020-06-06 Impact factor: 10.262